An 'omics approach towards CHO cell engineering

Biotechnology and Bioengineering

Volumn 110, Issue 5, 2013, Pages 1255-1271

  Datta, Payel ^a   Linhardt, Robert J ^a,b   Sharfstein, Susan T ^c  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Bioengineering; Chinese hamster ovary cells; Glycomics; Metabolic engineering

Indexed keywords

BIOPHARMACEUTICAL PRODUCTS; CHINESE HAMSTER OVARY CELLS; GLYCOMICS; HUMAN GROWTH HORMONE; INDUSTRIAL PRODUCTION; METABOLIC PATHWAYS; SUSPENSION CULTURES; TECHNIQUES AND TOOLS;

CELL CULTURE; CELL ENGINEERING; GENE EXPRESSION; GENETIC ENGINEERING; METABOLIC ENGINEERING; MONOCLONAL ANTIBODIES; SYSTEMS SCIENCE;

CELLS;

ABATACEPT; ADALIMUMAB; AFLIBERCEPT; AGALSIDASE BETA; ALEFACEPT; ALEMTUZUMAB; ALTEPLASE; BETA1A INTERFERON; BEVACIZUMAB; BLOOD CLOTTING FACTOR 8; CATHLO ACTIVASE; DENOSUMAB; EFALIZUMAB; GALSULFASE; IBRITUMOMAB TIUXETAN; LARONIDASE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OMALIZUMAB; PANITUMUMAB; PROTEOME; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; RECOMBINANT LUTEINIZING HORMONE; RECOMBINANT THROMBIN; RECOMBINANT THYROTROPIN; RILONACEPT; TENECTEPLASE; THROMBIN; TOCILIZUMAB; TRANSCRIPTOME; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE HEART INFARCTION; ANEMIA; ASTHMA; BIOPROCESS; BREAST CANCER; CELL CLONE; CELL ENGINEERING; CHO CELL; CHROMOSOME; CHRONIC LYMPHATIC LEUKEMIA; CINCA SYNDROME; COLON CANCER; COLORECTAL CANCER; FABRY DISEASE; GENETIC ENGINEERING; GENOME; GENOMICS; GLYCOBIOLOGY; GLYCOGEN STORAGE DISEASE TYPE 2; HEART INFARCTION; HEMOPHILIA A; HUMAN; HUNTER SYNDROME; INDUSTRIAL PRODUCTION; INFERTILITY; MAROTEAUX LAMY SYNDROME; METABOLIC ENGINEERING; METABOLOMICS; MULTIPLE SCLEROSIS; NONHODGKIN LYMPHOMA; NONHUMAN; POSTMENOPAUSE OSTEOPOROSIS; PROTEOMICS; PSORIASIS VULGARIS; RECOMBINANT DNA TECHNOLOGY; RECTUM CANCER; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RHEUMATOID ARTHRITIS; SUSPENSION CELL CULTURE; THYROID CANCER; TRANSCRIPTOMICS;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GENOMICS; GLYCOMICS; HUMANS; METABOLIC ENGINEERING; RECOMBINANT PROTEINS;

CRICETULUS GRISEUS;

EID: 84875517609     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24841     Document Type: Review

References (174)

1. Andersen MR, Hyun Nam J, Sharfstein ST. 2011. Protein Glycosylation: Analysis, Characterization, and Engineering. In: Flickinger M, editors. Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology. Hoboken, NJ: John Wiley & Sons, Inc. p 1-49.
2. Baik JY, Gasimli L, Yang B, Datta P, Zhang F, Glass CA, Esko JD, Linhardt RJ, Sharfstein ST. 2012. Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin. Metab Eng 14: 81-90. http://www.ncbi.nlm.nih.gov/pubmed/22326251
3. Baik JY, Lee GM. 2010. A DIGE approach for the assessment of differential expression of the CHO proteome under sodium butyrate addition: Effect of Bcl-x(L) overexpression. Biotechnol Bioeng 105: 358-367. http://www.ncbi.nlm.nih.gov/pubmed/19739093
4. Baik JY, Lee MS, An SR, Yoon SK, Joo EJ, Kim YH, Park HW, Lee GM. 2006. Initial transcriptome and proteome analyses of low culture temperature-induced expression in CHO cells producing erythropoietin. Biotechnol Bioeng 93: 361-371. http://www.ncbi.nlm.nih.gov/pubmed/16187333
5. Bailey CG, Tait AS, Sunstrom NA. 2002. High-throughput clonal selection of recombinant CHO cells using a dominant selectable and amplifiable metallothionein-GFP fusion protein. Biotechnol Bioeng 80: 670-676. DOI: 10.1002/bit.10424
6. Baldi L, Muller N, Picasso S, Jacquet R, Girard P, Thanh HP, Derow E, Wurm FM. 2005. Transient gene expression in suspension HEK-293 cells: Application to large-scale protein production. Biotechnol Prog 21: 148-153. http://www.ncbi.nlm.nih.gov/pubmed/15903252
7. Barnes LM, Bentley CM, Dickson AJ. 2001. Characterization of the stability of recombinant protein production in the GS-NS0 expression system. Biotechnol Bioeng 73: 261-270. http://www.ncbi.nlm.nih.gov/pubmed/11283909
8. Barron N, Kumar N, Sanchez N, Doolan P, Clarke C, Meleady P, O'Sullivan F, Clynes M. 2011. Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7. J Biotechnol 151: 204-211. http://www.ncbi.nlm.nih.gov/pubmed/21167223
9. Barron N, Kumar N, Sanchez N, Gammell P, Clynes M. 2012. MicroRNAs as potential engineering targets for improvement of CHO cell production Phenotypes. In: Jenkins N, Barron N, Alves P, editors. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. Vol. 5, p 3-11. Netherlands.
10. Baycin-Hizal D, Tabb DL, Chaerkady R, Chen L, Lewis NE, Nagarajan H, Sarkaria V, Kumar A, Wolozny D, Colao J, Jacobson E, Tian Y, O'Meally RN, Krag SS, Cole RN, Palsson BO, Zhang H, Betenbaugh M. 2012. Proteomic analysis of Chinese hamster ovary cells. J Proteome Res 11(11): 5265-5276. http://www.ncbi.nlm.nih.gov/pubmed/22971049
11. Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT. 1992. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Nat Biotechnol 10: 169-175.
12. Becerra S, Berrios J, Osses N, Altamirano C. 2012. Exploring the effect of mild hypothermia on CHO cell productivity. Biochem Eng J 60: 1-8. http://www.sciencedirect.com/science/article/pii/S1369703×11002804
13. Becker J, Timmermann C, Jakobi T, Rupp O, Szczepanowski R, Hackl M, Goesmann A, Tauch A, Borth N, Grillari J, Puhler A, Noll T, Brinkrolf K. 2011. Next-generation sequencing of the CHO cell transcriptome. BMC Proc 5(Suppl 8): P6. http://www.ncbi.nlm.nih.gov/pubmed/22373212
14. Benton T, Chen T, McEntee M, Fox B, King D, Crombie R, Thomas TC, Bebbington C. 2002. The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology 38: 43-46. http://www.ncbi.nlm.nih.gov/pubmed/19003085
15. Birch JR, Racher AJ. 2006. Antibody production. Adv Drug Deliv Rev 58: 671-685.
16. Bollin F, Dechavanne V, Chevalet L. 2011. Design of experiment in CHO and HEK transient transfection condition optimization. Protein Expr Purif 78: 61-68. http://www.sciencedirect.com/science/article/pii/S1046592811000465
17. Bort JA, Hackl M, Hoflmayer H, Jadhav V, Harreither E, Kumar N, Ernst W, Grillari J, Borth N. 2012. Dynamic mRNA and miRNA profiling of CHO-K1 suspension cell cultures. Biotechnol J 7: 500-515.
18. Borth N, Zeyda M, Kunert R, Katinger H. 2000. Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting. Biotechnol Bioeng 71: 266-273. http://www.ncbi.nlm.nih.gov/pubmed/11291036
19. Browne SM, Al-Rubeai M. 2007. Selection methods for high-producing mammalian cell lines. Trends Biotechnol 25: 425-432. http://www.ncbi.nlm.nih.gov/pubmed/17659798
20. Butler M. 2005. Animal cell cultures: Recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68: 283-291. http://www.ncbi.nlm.nih.gov/pubmed/15834715
21. Cabaniols J-P, Ouvry C, Lamamy V, Fery I, Craplet M-L, Moulharat N, Guenin S-P, Bedut S, Nosjean O, Ferry G, Devavry S, Jacqmarcq C, Lebuhotel C, Mathis L, Delenda C, Boutin JA, Duchâteau P, Cogé F, Pâques F. 2010. Meganuclease-driven targeted integration in CHO-K1 cells for the fast generation of HTS-compatible cell-based assays. J Biomol Screen 15: 956-967. http://jbx.sagepub.com/content/15/8/956.abstract
22. Cao Y, Kimura S, Itoi T, Honda K, Ohtake H, Omasa T. 2012. Construction of BAC-based physical map and analysis of chromosome rearrangement in Chinese hamster ovary cell lines. Biotechnol Bioeng 109: 1357-1367. DOI: 10.1002/bit.24347
23. Carlage T, Hincapie M, Zang L, Lyubarskaya Y, Madden H, Mhatre R, Hancock WS. 2009. Proteomic profiling of a high-producing Chinese hamster ovary cell culture. Anal Chem 81: 7357-7362.
24. Chakrabarti A, Chen AW, Varner JD. 2011. A review of the mammalian unfolded protein response. Biotechnol Bioeng 108: 2777-2793. http://www.ncbi.nlm.nih.gov/pubmed/21809331
25. Chong WPK, Goh LT, Reddy SG, Yusufi FNK, Lee DY, Wong NSC, Heng CK, Yap MGS, Ho YS. 2009. Metabolomics profiling of extracellular metabolites in recombinant Chinese Hamster Ovary fed-batch culture. Rapid Commun Mass Spectrom 23: 3763-3771. http://www.ncbi.nlm.nih.gov/pubmed/19902412
26. Chung JY, Ahn HK, Lim SW, Sung YH, Koh YW, Park SK, Lee GM. 2003. Development of recombinant Chinese hamster ovary cell lines producing human thrombopoietin or its analog. J Microb Biotechnol 13: 759-766.
27. Clarke C, Doolan P, Barron N, Meleady P, O'Sullivan F, Gammell P, Melville M, Leonard M, Clynes M. 2011. Predicting cell-specific productivity from CHO gene expression. J Biotechnol 151: 159-165. http://www.ncbi.nlm.nih.gov/pubmed/21115077
28. Cost GJ, Freyvert Y, Vafiadis A, Santiago Y, Miller JC, Rebar E, Collingwood TN, Snowden A, Gregory PD. 2010. BAK and BAX deletion using zinc-finger nucleases yields apoptosis-resistant CHO cells. Biotechnol Bioeng 105: 330-340. http://dx.doi.org/10.1002/bit.22541
29. Curran KA, Alper HS. 2012. Expanding the chemical palate of cells by combining systems biology and metabolic engineering. Metab Eng 14: 289-297. http://www.sciencedirect.com/science/article/pii/S1096717612000493
30. Dahodwala H, Nowey M, Mitina T, Sharfstein ST. 2012. Effects of clonal variation on growth, metabolism, and productivity in response to trophic factor stimulation: A study of Chinese hamster ovary cells producing a recombinant monoclonal antibody. Cytotechnology 64: 27-41. http://www.ncbi.nlm.nih.gov/pubmed/21822681
31. DeAngelis PL. 2012. Glycosaminoglycan polysaccharide biosynthesis and production: Today and tomorrow. Appl Microbiol Biotechnol 94: 295-305. http://www.ncbi.nlm.nih.gov/pubmed/22391966
32. Dietmair S, Hodson MP, Quek L-E, Timmins NE, Chrysanthopoulos P, Jacob SS, Gray P, Nielsen LK. 2012. Metabolite profiling of CHO cells with different growth characteristics. Biotechnol Bioeng 109: 1404-1414. http://dx.doi.org/10.1002/bit.24496
33. Dietmair S, Timmins NE, Gray PP, Nielsen LK, Krömer JO. 2010. Towards quantitative metabolomics of mammalian cells: Development of a metabolite extraction protocol. Anal Biochem 404: 155-164. http://www.sciencedirect.com/science/article/pii/S0003269710002836
34. Doolan P, Barron N, Kinsella P, Clarke C, Meleady P, O'Sullivan F, Melville M, Leonard M, Clynes M. 2012. Microarray expression profiling identifies genes regulating sustained cell specific productivity (S-Qp) in CHO K1 production cell lines. Biotechnol J 7: 516-526. http://www.ncbi.nlm.nih.gov/pubmed/22147654
35. Doolan P, Meleady P, Barron N, Henry M, Gallagher R, Gammell P, Melville M, Sinacore M, McCarthy K, Leonard M, Charlebois T, Clynes M. 2010. Microarray and proteomics expression profiling identifies several candidates, including the valosin-containing protein (VCP), involved in regulating high cellular growth rate in production CHO cell lines. Biotechnol Bioeng 106: 42-56. http://www.ncbi.nlm.nih.gov/pubmed/20091739
36. Dorai H, Ellis D, Keung YS, Campbell M, Zhuang M, Lin C, Betenbaugh MJ. 2010. Combining high-throughput screening of caspase activity with anti-apoptosis genes for development of robust CHO production cell lines. Biotechnol Prog 26: 1367-1381. http://dx.doi.org/10.1002/btpr.426
37. Dorai H, Kyung YS, Ellis D, Kinney C, Lin C, Jan D, Moore G, Betenbaugh MJ. 2009. Expression of anti-apoptosis genes alters lactate metabolism of Chinese Hamster Ovary cells in culture. Biotechnol Bioeng 103: 592-608. http://dx.doi.org/10.1002/bit.22269
38. Dwek RA. 1995. Glycobiology: More functions for oligosaccharides. Science 269: 1234-1235. http://www.ncbi.nlm.nih.gov/pubmed/7652569
39. Dwek RA. 1998. Biological importance of glycosylation. Dev Biol Stand 96: 43-47. http://www.ncbi.nlm.nih.gov/pubmed/9890515
40. Eisele F, Wolf DH. 2008. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1. FEBS Lett 582: 4143-4146. http://www.ncbi.nlm.nih.gov/pubmed/19041308
41. Esko JD, Selleck SB. 2002. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71: 435-471. http://www.ncbi.nlm.nih.gov/pubmed/12045103
42. Esko JD, Stanley P. 2009. Glycosylation mutants of cultured cells. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology, 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press.
43. Esko JD, Stewart TE, Taylor WH. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci USA 82: 3197-3201. http://www.ncbi.nlm.nih.gov/pubmed/3858816
44. Evans SV, Roger MacKenzie C. 1999. Characterization of protein-glycolipid recognition at the membrane bilayer. J Mol Recognit 12: 155-168. http://www.ncbi.nlm.nih.gov/pubmed/10398406
45. Flott S, Kwon Y, Pigli YZ, Rice PA, Sung P, Jackson SP. 2011. Regulation of Rad51 function by phosphorylation. EMBO Rep 12: 833-839. http://www.ncbi.nlm.nih.gov/pubmed/21738226
46. Freimark D, Jerome V, Freitag R. 2010. A GFP-based method facilitates clonal selection of transfected CHO cells. Biotechnol J 5: 24-31. DOI: 10.1002/biot.200800264
47. Freimark D, Jérôme V, Freitag R. 2012. Effect of process parameters and product-host-interaction on hVEGFA-production by recombinant Chinese hamster ovary cells. Biotechnol Prog 28: 762-772. http://dx.doi.org/10.1002/btpr.1524
48. Gaj T, Guo J, Kato Y, Sirk SJ, Barbas CF. 2012. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods 9: 805-807. http://www.nature.com/nmeth/journal/v9/n8/full/nmeth.2030.html
49. Gammell P, Barron N, Kumar N, Clynes M. 2007. Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells. J Biotechnol 130: 213-218. http://www.ncbi.nlm.nih.gov/pubmed/17570552
50. Girod PA, Nguyen DQ, Calabrese D, Puttini S, Grandjean M, Martinet D, Regamey A, Saugy D, Beckmann JS, Bucher P, Mermod N. 2007. Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. Nat Methods 4: 747-753. http://www.ncbi.nlm.nih.gov/pubmed/17676049
51. Girod PA, Zahn-Zabal M, Mermod N. 2005. Use of the chicken lysozyme 5′ matrix attachment region to generate high producer CHO cell lines. Biotechnol Bioeng 91: 1-11. http://www.ncbi.nlm.nih.gov/pubmed/15889435
52. Goldwasser E, Kung CK-H, Eliason J. 1974. On the mechanism of erythropoietin-induced differentiation. J Biol Chem 249: 4202-4206.
53. Gopalkrishnan RV, Christiansen KA, Goldstein NI, DePinho RA, Fisher PB. 1999. Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: A study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res 27: 4775-4782. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC148778/
54. Grabherr MG, Pontiller J, Mauceli E, Ernst W, Baumann M, Biagi T, Swofford R, Russell P, Zody MC, Di Palma F, Lindblad-Toh K, Grabherr RM. 2011. Exploiting nucleotide composition to engineer promoters. PLoS One 6: e20136. http://www.ncbi.nlm.nih.gov/pubmed/21625601
55. de Graffenried CL, Bertozzi CR. 2004. The roles of enzyme localisation and complex formation in glycan assembly within the Golgi apparatus. Curr Opin Cell Biol 16: 356-363. http://www.ncbi.nlm.nih.gov/pubmed/15261667
56. Graham FL, van der Eb AJ. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467. http://www.ncbi.nlm.nih.gov/pubmed/4705382
57. Griffin TJ, Seth G, Xie H, Bandhakavi S, Hu WS. 2007. Advancing mammalian cell culture engineering using genome-scale technologies. Trends Biotechnol 25: 401-408. http://www.ncbi.nlm.nih.gov/pubmed/17681628
58. Guerrini M, Zhang Z, Shriver Z, Masuko S, Langer R, Casu B, Linhardt RJ, Torri G, Sasisekharan R. 2009. Orthogonal analytical approaches to detect potential contaminants in heparin. Proceed Nat Acad Sci USA 106: 16956-16961.
59. Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, Chen X, Li L, Wu S, Chen Y, Jiang H, Tan L, Xie J, Zhu X, Liang S, Deng H. 2008. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin 40: 426-436. http://www.ncbi.nlm.nih.gov/pubmed/18465028
60. Gustafsson C, Minshull J, Govindarajan S, Ness J, Villalobos A, Welch M. 2012. Engineering genes for predictable protein expression. Protein Expr Purif 83: 37-46. http://www.sciencedirect.com/science/article/pii/S1046592812000629
61. Hackl M, Jakobi T, Blom J, Doppmeier D, Brinkrolf K, Szczepanowski R, Bernhart SH, Siederdissen CH, Bort JA, Wieser M, Kunert R, Jeffs S, Hofacker IL, Goesmann A, Puhler A, Borth N, Grillari J. 2011. Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering. J Biotechnol 153: 62-75.
62. Hackl M, Jadhav V, Jakobi T, Rupp O, Brinkrolf K, Goesmann A, Pühler A, Noll T, Borth N, Grillari J. 2012. Computational identification of microRNA gene loci and precursor microRNA sequences in CHO cell lines. J Biotechnol 158: 151-155. http://www.ncbi.nlm.nih.gov/pubmed/22306111
63. Haltiwanger RS, Lowe JB. 2004. Role of glycosylation in development. Annu Rev Biochem 73: 491-537. http://www.ncbi.nlm.nih.gov/pubmed/15189151
64. Hammill L, Welles J, Carson GR. 2000. The gel microdrop secretion assay: Identification of a low productivity subpopulation arising during the production of human antibody in CHO cells. Cytotechnology 34: 27-37. http://www.ncbi.nlm.nih.gov/pubmed/19003378
65. Hammond S, Swanberg JC, Polson SW, Lee KH. 2012. Profiling conserved microRNA expression in recombinant CHO cell lines using illumina sequencing. Biotechnol Bioeng 109: 1371-1375. http://www.ncbi.nlm.nih.gov/pubmed/22189905
66. Hayter PM, Curling EM, Baines AJ, Jenkins N, Salmon I, Strange PG, Tong JM, Bull AT. 1992. Glucose-limited chemostat culture of Chinese hamster ovary cells producing recombinant human interferon-gamma. Biotechnol Bioeng 39: 327-335. http://www.ncbi.nlm.nih.gov/pubmed/18600949
67. Hong WW, Wu SC. 2007. A novel RNA silencing vector to improve antigen expression and stability in Chinese hamster ovary cells. Vaccine 25: 4103-4111. http://www.ncbi.nlm.nih.gov/pubmed/17428585
68. Huang Y, Li Y, Wang YG, Gu X, Wang Y, Shen BF. 2007. An efficient and targeted gene integration system for high-level antibody expression. J Immunol Methods 322: 28-39. http://www.ncbi.nlm.nih.gov/pubmed/17350648
69. Huang Y-M, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T. 2010. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog 26: 1400-1410. http://dx.doi.org/10.1002/btpr.436
70. Jadhav V, Hackl M, Hernandez BortJA, Wieser M, Harreither E, Kunert R, Borth N, Grillari J. 2012. A screening method to assess biological effects of microRNA overexpression in Chinese hamster ovary cells. Biotechnol Bioeng 109: 1376-1385. DOI: 10.1002/bit.24490
71. Jardon MA, Sattha B, Braasch K, Leung AO, Côté HCF, Butler M, Gorski SM, Piret JM. 2012. Inhibition of glutamine-dependent autophagy increases t-PA production in CHO Cell fed-batch processes. Biotechnol Bioeng 109: 1228-1238. http://dx.doi.org/10.1002/bit.24393
72. Jayapal KP, Wlaschin KF, Hu W-S, Yap MGS. 2007. Recombinant protein therapeutics from Cho Cells-20 years and counting. CHO Consortium: SBE Special Edition: 40-47.
73. Jenkins N, Parekh RB, James DC. 1996. Getting the glycosylation right: Implications for the biotechnology industry. Nat Biotechnol 14: 975-981.
74. Jeon M, Yu D, Lee G. 2011. Combinatorial engineering of ldh-a and bcl-2 for reducing lactate production and improving cell growth in dihydrofolate reductase-deficient Chinese hamster ovary cells. Appl Microbiol Biotechnol 92: 779-790. http://dx.doi.org/10.1007/s00253-011-3475-0
75. Jeong YT, Choi O, Son YD, Park SY, Kim JH. 2009. Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese-hamster ovary cells. Biotechnol Appl Biochem 52: 283-291. http://www.ncbi.nlm.nih.gov/pubmed/18590515
76. Jiang Z, Sharfstein ST. 2008. Sodium butyrate stimulates monoclonal antibody over-expression in CHO cells by improving gene accessibility. Biotechnol Bioeng 100: 189-194. http://www.ncbi.nlm.nih.gov/pubmed/18023047
77. Jing Y, Borys M, Nayak S, Egan S, Qian Y, Pan S-H, Li ZJ. 2012a. Identification of cell culture conditions to control protein aggregation of IgG fusion proteins expressed in Chinese hamster ovary cells. Process Biochem 47: 69-75.
78. Jing Y, Qian Y, Ghandi M, He A, Borys MC, Pan SH, Li ZJ. 2012b. A mechanistic study on the effect of dexamethasone in moderating cell death in Chinese Hamster Ovary cell cultures. Biotechnol Prog 28: 490-496. http://www.ncbi.nlm.nih.gov/pubmed/22140034
79. Johnson KC, Jacob NM, Nissom PM, Hackl M, Lee LH, Yap M, Hu WS. 2011. Conserved microRNAs in Chinese hamster ovary cell lines. Biotechnol Bioeng 108: 475-480. http://www.ncbi.nlm.nih.gov/pubmed/20830683
80. Jones D, Kroos N, Anema R, van Montfort B, Vooys A, van der Kraats S, van der Helm E, Smits S, Schouten J, Brouwer K, Lagerwerf F, van Berkel P, Opstelten DJ, Logtenberg T, Bout A. 2003. High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 19: 163-168. http://www.ncbi.nlm.nih.gov/pubmed/12573020
81. Kacmar J, Srienc F. 2005. Dynamics of single cell property distributions in Chinese hamster ovary cell cultures monitored and controlled with automated flow cytometry. J Biotechnol 120: 410-420. http://www.ncbi.nlm.nih.gov/pubmed/16144728
82. Kaneko Y, Nimmerjahn F, Ravetch JV. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313: 670-673. http://www.sciencemag.org/content/313/5787/670.abstract
83. Kantardjieff A, Jacob NM, Yee JC, Epstein E, Kok YJ, Philp R, Betenbaugh M, Hu WS. 2010. Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment. J Biotechnol 145: 143-159.
84. Kaufman RJ, Wasley LC, Spiliotes AJ, Gossels SD, Latt SA, Larsen GR, Kay RM. 1985. Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells. Mol Cell Biol 5: 1750-1759. http://www.ncbi.nlm.nih.gov/pubmed/4040603
85. Kim JM, Kim JS, Park DH, Kang HS, Yoon J, Baek K, Yoon Y. 2004. Improved recombinant gene expression in CHO cells using matrix attachment regions. J Biotechnol 107: 95-105. http://www.ncbi.nlm.nih.gov/pubmed/14711493
86. Kim JY, Kim YG, Lee GM. 2012a. CHO cells in biotechnology for production of recombinant proteins: Current state and further potential. Appl Microbiol Biotechnol 93: 917-930. http://www.ncbi.nlm.nih.gov/pubmed/22159888
87. Kim JY, Kim Y-G, Lee GM. 2012b. Differential in-gel electrophoresis (DIGE) analysis of CHO cells under hyperosmotic pressure: Osmoprotective effect of glycine betaine addition. Biotechnol Bioeng 109: 1395-1403. http://dx.doi.org/10.1002/bit.24442
88. Kim NS, Kim SJ, Lee GM. 1998. Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: Stability in the absence of selective pressure. Biotechnol Bioeng 60: 679-688. http://dx.doi.org/10.1002/(SICI)1097-0290(19981220)60:6<679::AID-BIT5>3.0.CO;2-Q
89. Kim SH, Lee GM. 2007. Down-regulation of lactate dehydrogenase-A by siRNAs for reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin. Appl Microbiol Biotechnol 74: 152-159. http://www.ncbi.nlm.nih.gov/pubmed/17086415
90. Kim S, Lee G. 2009. Development of serum-free medium supplemented with hydrolysates for the production of therapeutic antibodies in CHO cell cultures using design of experiments. Appl Microbiol Biotechnol 83: 639-648. http://dx.doi.org/10.1007/s00253-009-1903-1
91. Kito M, Itami S, Fukano Y, Yamana K, Shibui T. 2002. Construction of engineered CHO strains for high-level production of recombinant proteins. Appl Microbiol Biotechnol 60: 442-448. http://www.ncbi.nlm.nih.gov/pubmed/12466885
92. Klapperstuck T, Glanz D, Klapperstuck M, Wohlrab J. 2009. Methodological aspects of measuring absolute values of membrane potential in human cells by flow cytometry. Cytometry A 75: 593-608.
93. Klausing S, Kramer O, Noll T. 2011. Bioreactor cultivation of CHO DP-12 cells under sodium butyrate treatment-Comparative transcriptome analysis with CHO cDNA microarrays. BMC Proc 5(Suppl 8): P98. http://www.ncbi.nlm.nih.gov/pubmed/22373269
94. Kumar N, Maurya P, Gammell P, Dowling P, Clynes M, Meleady P. 2008. Proteomic profiling of secreted proteins from CHO cells using Surface-Enhanced Laser desorption ionization time-of-flight mass spectrometry. Biotechnol Prog 24: 273-278. http://www.ncbi.nlm.nih.gov/pubmed/18163642
95. Kumar N, Borth N. 2012. Flow-cytometry and cell sorting: An efficient approach to investigate productivity and cell physiology in mammalian cell factories. Methods 56: 366-374. http://www.sciencedirect.com/science/article/pii/S1046202312000515
96. Kuystermans D, Krampe B, Swiderek H, Al-Rubeai M. 2007. Using cell engineering and omic tools for the improvement of cell culture processes. Cytotechnology 53: 3-22. http://www.ncbi.nlm.nih.gov/pubmed/19003186
97. Kwaks TH, Barnett P, Hemrika W, Siersma T, Sewalt RG, Satijn DP, Brons JF, van Blokland R, Kwakman P, Kruckeberg AL, Kelder A, Otte AP. 2003. Identification of anti-repressor elements that confer high and stable protein production in mammalian cells. Nat Biotechnol 21: 553-558. http://www.ncbi.nlm.nih.gov/pubmed/12679786
98. Kwaks TH, Otte AP. 2006. Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends Biotechnol 24: 137-142. http://www.ncbi.nlm.nih.gov/pubmed/16460822
99. Kwok-Keung Chan K, Meiyun Wu S, Morin Nissom P, Oh SKW, Choo ABH. 2008. Generation of high-level stable transgene expressing human embryonic stem cell lines using chinese hamster elongation factor-1α promoter system. Stem Cells Dev 17: 825-836. http://www.ncbi.nlm.nih.gov/pubmed/18788934
100. Lee JS, Lee GM. 2012. Monitoring of autophagy in Chinese hamster ovary cells using flow cytometry. Methods 56: 375-382. http://www.ncbi.nlm.nih.gov/pubmed/22142658
101. Lee JW, Na D, Park JM, Lee J, Choi S, Lee SY. 2012. Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol 8: 536-546. http://dx.doi.org/10.1038/nchembio.970
102. Legmann R, Schreyer HB, Combs RG, McCormick EL, Russo AP, Rodgers ST. 2009. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells. Biotechnol Bioeng 104: 1107-1120. http://dx.doi.org/10.1002/bit.22474
103. Li J, Wong CL, Vijayasankaran N, Hudson T, Amanullah A. 2012. Feeding lactate for CHO cell culture processes: Impact on culture metabolism and performance. Biotechnol Bioeng 109: 1173-1186. http://dx.doi.org/10.1002/bit.24389
104. Lim SF, Chuan KH, Liu S, Loh SO, Chung BY, Ong CC, Song Z. 2006. RNAi suppression of Bax and Bak enhances viability in fed-batch cultures of CHO cells. Metab Eng 8: 509-522. http://www.ncbi.nlm.nih.gov/pubmed/16860584
105. Lin N, Davis A, Bahr S, Borgschulte T, Achtien K, Kayser K. 2011. Profiling highly conserved microrna expression in recombinant IgG-producing and parental Chinese hamster ovary cells. Biotechnol Prog 27: 1163-1171. http://www.ncbi.nlm.nih.gov/pubmed/21692195
106. Liu H, Zhang Z, Linhardt RJ. 2009. Lessons learned from the contamination of heparin. Nat Prod Rep 26: 313-321. http://www.ncbi.nlm.nih.gov/pubmed/19240943
107. Lu H, Wang X, Li T, Urvalek AM, Yu L, Li J, Zhu J, Lin Q, Peng X, Zhao J. 2011. Identification of poly (ADP-ribose) polymerase-1 (PARP-1) as a novel Kruppel-like factor 8-interacting and -regulating protein. J Biol Chem 286: 20335-20344. http://www.ncbi.nlm.nih.gov/pubmed/21518760
108. Ma N, Ellet J, Okediadi C, Hermes P, McCormick E, Casnocha S. 2009. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism. Biotechnol Prog 25: 1353-1363. http://dx.doi.org/10.1002/btpr.238
109. Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG. 2009. Mcl-1 overexpression leads to higher viabilities and increased production of humanized monoclonal antibody in Chinese hamster ovary cells. Biotechnol Prog 25: 1161-1168. http://dx.doi.org/10.1002/btpr.192
110. Markely LRA, Ong BT, Hoi KM, Teo G, Lu MY, Wang DIC. 2010. A high-throughput method for quantification of glycoprotein sialylation. Anal Biochem 407: 128-133. http://www.sciencedirect.com/science/article/pii/S0003269710004902
111. Meleady P. 2007. Proteomic profiling of recombinant cells from large-scale mammalian cell culture processes. Cytotechnology 53: 23-31. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267616
112. Meleady P, Gallagher M, Clarke C, Henry M, Sanchez N, Barron N, Clynes M. 2012a. Impact of miR-7 over-expression on the proteome of Chinese hamster ovary cells. J Biotechnol 160(3-4): 251-262. http://www.ncbi.nlm.nih.gov/pubmed/22445466
113. Meleady P, Henry M, Gammell P, Doolan P, Sinacore M, Melville M, Francullo L, Leonard M, Charlebois T, Clynes M. 2008. Proteomic profiling of CHO cells with enhanced rhBMP-2 productivity following co-expression of PACEsol. Proteomics 8: 2611-2624. http://www.ncbi.nlm.nih.gov/pubmed/18546152
114. Meleady P, Hoffrogge R, Henry M, Rupp O, Bort JH, Clarke C, Brinkrolf K, Kelly S, Muller B, Doolan P, Hackl M, Beckmann TF, Noll T, Grillari J, Barron N, Puhler A, Clynes M, Borth N. 2012b. Utilization and evaluation of CHO-specific sequence databases for mass spectrometry based proteomics. Biotechnol Bioeng 109: 1386-1394. http://www.ncbi.nlm.nih.gov/pubmed/22389098
115. Meleady P, Doolan P, Henry M, Barron N, Keenan J, O'Sullivan F, Clarke C, Gammell P, Melville M, Leonard M, Clynes M. 2011. Sustained productivity in recombinant Chinese Hamster Ovary (CHO) cell lines: Proteome analysis of the molecular basis for a process-related phenotype. BMC Biotechnol 11: 78. http://www.biomedcentral.com/1472-6750/11/78
116. Melville M, Doolan P, Mounts W, Barron N, Hann L, Leonard M, Clynes M, Charlebois T. 2011. Development and characterization of a Chinese hamster ovary cell-specific oligonucleotide microarray. Biotechnol Lett 33: 1773-1779. http://www.ncbi.nlm.nih.gov/pubmed/21547514
117. Mohan C, Kim Y-G, Koo J, Lee GM. 2008. Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells. Biotechnol J 3: 624-630. http://dx.doi.org/10.1002/biot.200700249
118. Mohan C, Kim Y-G, Lee GM. 2009. Apoptosis and autophagy cell engineering. In: Al-Rubeai M, editor. Cell line development. Vol. 6. Netherlands: Springer. p 195-216.
119. Mori K, Kuni-Kamochi R, Yamane-Ohnuki N, Wakitani M, Yamano K, Imai H, Kanda Y, Niwa R, Iida S, Uchida K, Shitara K, Satoh M. 2004. Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. Biotechnol Bioeng 88: 901-908. http://www.ncbi.nlm.nih.gov/pubmed/15515168
120. Muller D, Katinger H, Grillari J. 2008. MicroRNAs as targets for engineering of CHO cell factories. Trends Biotechnol 26: 359-365. http://www.ncbi.nlm.nih.gov/pubmed/18471912
121. Nam JH, Zhang F, Ermonval M, Linhardt RJ, Sharfstein ST. 2008. The effects of culture conditions on the glycosylation of secreted human placental alkaline phosphatase produced in Chinese hamster ovary cells. Biotechnol Bioeng 100: 1178-1192. http://www.ncbi.nlm.nih.gov/pubmed/18553404
122. Ngantung FA, Miller PG, Brushett FR, Tang GL, Wang DI. 2006. RNA interference of sialidase improves glycoprotein sialic acid content consistency. Biotechnol Bioeng 95: 106-119. http://www.ncbi.nlm.nih.gov/pubmed/16673415
123. Nicolette J, Diehl M, Sonders P, Bryce S, Blomme E. 2011. In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells. Environ Mol Mutagen 52: 355-362. http://www.ncbi.nlm.nih.gov/pubmed/20963813
124. Nissom PM, Sanny A, Kok YJ, Hiang YT, Chuah SH, Shing TK, Lee YY, Wong KT, Hu WS, Sim MY, Philp R. 2006. Transcriptome and proteome profiling to understanding the biology of high productivity CHO cells. Mol Biotechnol 34: 125-140. http://www.ncbi.nlm.nih.gov/pubmed/17172658
125. Noguchi A, Mukuria CJ, Suzuki E, Naiki M. 1995. Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. J Biol Chem 117: 59-62. http://jb.oxfordjournals.org/content/117/1/59
126. North SJ, Huang HH, Sundaram S, Jang-Lee J, Etienne AT, Trollope A, Chalabi S, Dell A, Stanley P, Haslam SM. 2010. Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity. J Biol Chem 285: 5759-5775. http://www.ncbi.nlm.nih.gov/pubmed/19951948
127. Omasa T, Onitsuka M, Kim WD. 2010. Cell engineering and cultivation of Chinese hamster ovary (CHO) cells. Curr Pharm Biotechnol 11: 233-240. http://www.ncbi.nlm.nih.gov/pubmed/20210750
128. Park S, Kim W, Kim Y, Son YD, Lee S-C, Kim E, Kim SH, Kim JH, Kim H-S. 2010. Array-based analysis of secreted glycoproteins for rapid selection of a single cell producing a glycoprotein with desired glycosylation. Anal Chem 82: 5830-5837. http://dx.doi.org/10.1021/ac100992n
129. Paulson JC, Colley KJ. 1989. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 264: 17615-17618.
130. Pichler J, Galosy S, Mott J, Borth N. 2011. Selection of CHO host cell subclones with increased specific antibody production rates by repeated cycles of transient transfection and cell sorting. Biotechnol Bioeng 108: 386-394. http://dx.doi.org/10.1002/bit.22946
131. Pilbrough W, Munro TP, Gray P. 2009. Intraclonal protein expression heterogeneity in recombinant CHO cells. PLoS ONE 4: e8432. http://dx.doi.org/10.1371/journal.pone.0008432
132. Prati EG, Scheidegger P, Sburlati AR, Bailey JE. 1998. Antisense strategies for glycosylation engineering of Chinese hamster ovary (CHO) cells. BiotechnolBioeng 59(4): 445-450. http://www.ncbi.nlm.nih.gov/pubmed/10099358
133. Puck TT, Marcus PI. 1955. A rapid method for viable cell titration and clone production with hela cells in tissue culture: The use of X-irradiated cells to supply conditioning factors. Proc Natl Acad Sci USA 41: 432-437. http://www.ncbi.nlm.nih.gov/pubmed/16589695
134. Ringold G, Dieckmann B, Lee F. 1981. Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells. J Mol Appl Genet 1: 165-175. http://www.ncbi.nlm.nih.gov/pubmed/6180118
135. Rouiller Y, Périlleux A, Marsaut M, Stettler M, Vesin M-N, Broly H. 2012. Effect of hydrocortisone on the production and glycosylation of an Fc-fusion protein in CHO cell cultures. Biotechnol Prog 28: 803-813. http://dx.doi.org/10.1002/btpr.1530
136. Running Deer J, Allison DS. 2004. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene. Biotechnol Prog 20: 880-889. http://www.ncbi.nlm.nih.gov/pubmed/15176895
137. Sellick CA, Hansen R, Maqsood AR, Dunn WB, Stephens GM, Goodacre R, Dickson AJ. 2009. Effective quenching processes for physiologically valid metabolite profiling of suspension cultured mammalian cells. Anal Chem 81: 174-183. http://pubs.acs.org/doi/abs/10.1021/ac8016899
138. Selvarasu S, Ho YS, Chong WP, Wong NS, Yusufi FN, Lee YY, Yap MG, Lee DY. 2012. Combined in silico modeling and metabolomics analysis to characterize fed-batch CHO cell culture. Biotechnol Bioeng 109: 1415-1429. http://www.ncbi.nlm.nih.gov/pubmed/22252269
139. Seth G, Charaniya S, Wlaschin KF, Hu WS. 2007. In pursuit of a super producer-alternative paths to high producing recombinant mammalian cells. Curr Opin Biotechnol 18: 557-564. http://www.ncbi.nlm.nih.gov/pubmed/18082393
140. Sharon N, Lis H. 1993. Carbohydrates in cell recognition. Sci Am 268: 82-89. http://www.ncbi.nlm.nih.gov/pubmed/7678182
141. Shen D, Kiehl TR, Khattak SF, Li ZJ, He A, Kayne PS, Patel V, Neuhaus IM, Sharfstein ST. 2010. Transcriptomic responses to sodium chloride-induced osmotic stress: A study of industrial fed-batch CHO cell cultures. Biotechnol Prog 26: 1104-1115. http://www.ncbi.nlm.nih.gov/pubmed/20306541
142. Shi S, Condon RG, Deng L, Saunders J, Hung F, Tsao YS, Liu Z. 2011. A high-throughput automated platform for the development of manufacturing cell lines for protein therapeutics. J Vis Exp (55): e3010
143. Silva G, Poirot L, Galetto R, Smith J, Montoya G, Duchateau P, Paques F. 2011. Meganucleases and other tools for targeted genome engineering: Perspectives and challenges for gene therapy. Curr Gene Ther 11: 11-27. http://www.hubmed.org/display.cgi?uids=21182466
144. Sinclair AM, Elliott S. 2005. Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci 94: 1626-1635. http://www.ncbi.nlm.nih.gov/pubmed/15959882
145. Son Y-D, Jeong YT, Park S-Y, Kim JH. 2011. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes. Glycobiology 21: 1019-1028. http://www.ncbi.nlm.nih.gov/pubmed/21436238
146. Sung YH, Hwang SJ, Lee GM. 2005. Influence of down-regulation of caspase-3 by siRNAs on sodium-butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin. Metab Eng 7: 457-466. http://www.ncbi.nlm.nih.gov/pubmed/16169764
147. Sung YH, Lee JS, Park SH, Koo J, Lee GM. 2007. Influence of co-down-regulation of caspase-3 and caspase-7 by siRNAs on sodium butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin. Metab Eng 9: 452-464. http://www.ncbi.nlm.nih.gov/pubmed/17892962
148. Szperalski B, Jung C, Shao Z, Kantardjieff A, Hu WS. 2011. LDH-C can be differentially expressed during fermentation of CHO cells. BMC Proc 5(Suppl 8): P107. http://www.ncbi.nlm.nih.gov/pubmed/22373157
149. Tep S, Hincapie M, Hancock WS. 2012. The characterization and quantitation of glycomic changes in CHO cells during a bioreactor campaign. Biotechnol Bioeng 109: 3007-3017. http://www.ncbi.nlm.nih.gov/pubmed/22752974
150. Tsuda E, Kawanishi G, Ueda M, Masuda S, Sasaki R. 1990. The role of carbohydrate in recombinant human erythropoietin. Eur J Biochem 188: 405-411. http://www.ncbi.nlm.nih.gov/pubmed/2156701
151. Taschwer M, Hackl M, Bort JAH, Leitner C, Kumar N, Puc U, Grass J, Papst M, Kunert R, Altmann F, Borth N. 2012. Growth, productivity and protein glycosylation in a CHO EpoFc producer cell line adapted to glutamine-free growth. J Biotechnol 157: 295-303. http://www.ncbi.nlm.nih.gov/pubmed/22178781
152. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. 2006. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524. http://www.ncbi.nlm.nih.gov/pubmed/16510870
153. Valleriani A, Zhang G, Nagar A, Ignatova Z, Lipowsky R. 2011. Length-dependent translation of messenger RNA by ribosomes. Phys Rev E Stat Nonlin Soft Matter Phys 83: 0429031-0429034. http://www.ncbi.nlm.nih.gov/pubmed/21599226
154. Vanderbyl S, MacDonald N, de Jong G. 2001. A flow cytometry technique for measuring chromosome-mediated gene transfer. Cytometry 44: 100-105. http://www.ncbi.nlm.nih.gov/pubmed/11378859
155. Varki A. 1993. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3: 97-130. http://www.ncbi.nlm.nih.gov/pubmed/8490246
156. Varki A. 1998. Factors controlling the glycosylation potential of the Golgi apparatus. Trends Cell Biol 8: 34-40. http://www.ncbi.nlm.nih.gov/pubmed/9695806
157. Walsh G. 2010. Biopharmaceutical benchmarks 2010. Nat Biotechnol 28: 917-924. http://www.ncbi.nlm.nih.gov/pubmed/20829826
158. Walsh G, Jefferis R. 2006. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 24: 1241-1252. http://www.ncbi.nlm.nih.gov/pubmed/17033665
159. Wilson C, Bellen HJ, Gehring WJ. 1990. Position effects on eukaryotic gene expression. Annu Rev Cell Biol 6: 679-714. http://www.ncbi.nlm.nih.gov/pubmed/2275824
160. Wlaschin KF, Hu W-S. 2007. Engineering cell metabolism for high-density cell culture via manipulation of sugar transport. J Biotechnol 131: 168-176. http://www.ncbi.nlm.nih.gov/pubmed/17662499
161. Wlaschin KF, Nissom PM, Gatti Mde L, Ong PF, Arleen S, Tan KS, Rink A, Cham B, Wong K, Yap M, Hu WS. 2005. EST sequencing for gene discovery in Chinese hamster ovary cells. Biotechnol Bioeng 91: 592-606. http://www.ncbi.nlm.nih.gov/pubmed/16003777
162. Wong DC, Wong KT, Nissom PM, Heng CK, Yap MG. 2006a. Targeting early apoptotic genes in batch and fed-batch CHO cell cultures. Biotechnol Bioeng 95: 350-361. http://www.ncbi.nlm.nih.gov/pubmed/16894638
163. Wong NS, Yap MG, Wang DI. 2006b. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells. Biotechnol Bioeng 93: 1005-1016. http://www.ncbi.nlm.nih.gov/pubmed/16432895
164. Wu SC. 2009. RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells. Biotechnol Adv 27: 417-422. http://www.ncbi.nlm.nih.gov/pubmed/19289164
165. Wu SC, Hong WW, Liu JH. 2008. Short hairpin RNA targeted to dihydrofolate reductase enhances the immunoglobulin G expression in gene-amplified stable Chinese hamster ovary cells. Vaccine 26: 4969-4974. http://www.ncbi.nlm.nih.gov/pubmed/18602963
166. Wurm FM. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22: 1393-1398. http://www.ncbi.nlm.nih.gov/pubmed/15529164
167. Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, Chen W, Xie M, Wang W, Hammond S, Andersen MR, Neff N, Passarelli B, Koh W, Fan HC, Wang J, Gui Y, Lee KH, Betenbaugh MJ, Quake SR, Famili I, Palsson BO. 2011. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 29: 735-741. http://www.ncbi.nlm.nih.gov/pubmed/21804562
168. Yamane-Ohnuki N, Kinoshita S, Inoue-Urakubo M, Kusunoki M, Iida S, Nakano R, Wakitani M, Niwa R, Sakurada M, Uchida K, Shitara K, Satoh M. 2004. Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng 87: 614-622. http://www.ncbi.nlm.nih.gov/pubmed/15352059
169. Yee JC, de Leon Gatti M, Philp RJ, Yap M, Hu WS. 2008a. Genomic and proteomic exploration of CHO and hybridoma cells under sodium butyrate treatment. Biotechnol Bioeng 99: 1186-1204. http://www.ncbi.nlm.nih.gov/pubmed/17929327
170. Yee JC, Wlaschin KF, Chuah SH, Nissom PM, Hu W-S. 2008b. Quality assessment of cross-species hybridization of CHO transcriptome on a mouse DNA oligo microarray. Biotechnol Bioeng 101: 1359-1365. http://www.ncbi.nlm.nih.gov/pubmed/18814282
171. Zahn-Zabal M, Kobr M, Girod PA, Imhof M, Chatellard P, de Jesus M, Wurm F, Mermod N. 2001. Development of stable cell lines for production or regulated expression using matrix attachment regions. J Biotechnol 87: 29-42. http://www.ncbi.nlm.nih.gov/pubmed/11267697
172. Zhang L, Lawrence R, Frazier BA, Esko JD. 2006. CHO glycosylation mutants: Proteoglycans. Methods Enzymol 416: 205-221. http://www.ncbi.nlm.nih.gov/pubmed/17113868
173. Zhou M, Crawford Y, Ng D, Tung J, Pynn AFJ, Meier A, Yuk IH, Vijayasankaran N, Leach K, Joly J, Snedecor B, Shen A. 2011. Decreasing lactate level and increasing antibody production in Chinese Hamster Ovary cells (CHO) by reducing the expression of lactate dehydrogenase and pyruvate dehydrogenase kinases. J Biotechnol 153: 27-34. http://www.sciencedirect.com/science/article/pii/S0168165611001143
174. Zhu J. 2012. Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30: 1158-1170. http://www.ncbi.nlm.nih.gov/pubmed/21968146